Vivoryon Therapeutics N.V. to Attend and Present in Upcoming Conferences

Summary by AI BETAClose X

Vivoryon Therapeutics N.V. announced its management will participate in several upcoming medical and investor conferences, including the J.P. Morgan Healthcare Conference from January 12-14, 2026, the UBS European Healthcare Conference on March 3-4, 2026, and the World Congress of Nephrology in Yokohama, Japan, from March 28-31, 2026. These presentations will provide updates on the company's clinical-stage development of small molecule medicines for inflammatory and fibrotic disorders, with a particular focus on kidney diseases, including its lead program varoglutamstat for diabetic kidney disease.

Disclaimer*

UK 100

Latest directors dealings